Abstract
Protein regulator of cytokinesis 1 (PRC1) has been reported to be implicated into the completion of cytokinesis and is dys-regulated in a cancer-specific manner. However, it roles in human prostate cancer (PCa) remain unclear. In the current study, we aimed to investigate the expression pattern of PRC1 and its clinical significance in this malignancy. PRC1 protein expression in human PCa and non-cancerous prostate tissues was detected by immunohistochemistry, which was validated by microarray-based Taylor data at mRNA level. Then, the associations of PRC1 expression with clinicopathological features and clinical outcome of PCa patients were statistically analyzed. PRC1 expression in PCa tissues, at both mRNA and protein levels, were significantly higher than those in non-cancerous prostate tissues. In addition, the PCa patients with PRC1 overexpression more frequently had high Gleason score, advanced pathological stage, positive metastasis, short overall survival time and positive PSA failure than those with low Gleason score, early pathological stage, negative metastasis, long overall survival time and negative PSA failure (all P<0.05). Moreover, PRC1 expression was identified as an unfavorable prognostic factor of biochemical...Continue Reading
References
Nov 9, 2004·Oncogene·Cong LiJingwen Liu
Dec 25, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S K PathakA J Gescher
May 18, 2005·Oncogene·Quentin FeltyDeodutta Roy
Apr 6, 2007·Cancer Research·Mitsugu KanehiraYusuke Nakamura
Jan 30, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hao TangYang Xie
May 8, 2013·International Journal of Molecular Sciences·Giorgio MustacchiLuca Morandi
Jun 13, 2013·International Journal of Radiation Oncology, Biology, Physics·Stephen J FreedlandSteven Stone
Jan 3, 2014·International Journal of Cancer. Journal International Du Cancer·Zhuo-Yuan LinChin-Lee Wu
Apr 10, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Maryam EsfahaniMojtaba Panjehpour
Jun 7, 2015·Urology·Eliney F FariaSurena F Matin
Jun 13, 2015·The Lancet Oncology·David LorenteGerhardt Attard
Jun 24, 2015·British Journal of Cancer·J CuzickP Scardino
Jul 15, 2015·Prostate International·Susan Marshall, Samir Taneja
Jul 22, 2015·The Journal of Urology·E David CrawfordDaniel P Petrylak
Jul 27, 2015·Cancer Treatment Reviews·Galina KhemlinaRazelle Kurzrock
Aug 19, 2015·Urology·Fred Saad, Karim S Fizazi
Citations
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Veronika BrynychovaPavel Soucek
Jul 26, 2019·Biological Reviews of the Cambridge Philosophical Society·Zhen-Yu SheMing-Hui Lu
Feb 19, 2019·International Journal of Endocrinology·Xueren GaoShulong Zhang
Aug 31, 2020·Cancer Cell International·Yuanji XuChuanben Chen
Jan 16, 2019·Journal of Cancer Research and Clinical Oncology·Fang PengYong Bao
Apr 18, 2019·Journal of Cellular Physiology·Liang YiXin-Ming Yang
Dec 10, 2020·Cancer Cell International·Tianxiang XuWu Ji
Jun 24, 2021·Science Signaling·Mary L UribeYosef Yarden
Aug 13, 2021·Bioengineered·Gang ChenGuangdong Qiao